MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-02-0045523
Retort Pharmaceuticals Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹1.97 Cr
▼ 7% YoY
Net loss · FY 2024
₹3.34 Lakh
Net margin -1.7%
EBITDA · FY 2024
₹64,813
EBITDA margin 0.3%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹2.5 Lakh
Issued & subscribed
Open charges
₹4.7 Lakh
Satisfied ₹16 Lakh
Company age
43 yrs
Est. 1983
Employees · EPFO
30
Provident fund records
About Retort Pharmaceuticals Private Limited
Data last updated:
Retort Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 October 1983 and has been in existence for over 43 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24231TN1983PTC010371. Its GSTIN is 33AAACR2993J1Z7 (Tamil Nadu).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2.5 Lakh. It is led by directors Nandita Thakkar and Varun Ashok Thakkar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 21 Mc. Nichols Road Chetput Madras – 31., Chennai, Tamil Nadu, India – 600031.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.97 Cr, a decline of 7% compared to the previous year. For the same year it recorded a net loss of ₹3.34 Lakh (net margin -1.7%) and EBITDA of ₹64,813 (EBITDA margin 0.3%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years and 2% over five years.
The company has about 30 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹4.7 Lakh and satisfied charges of ₹16 Lakh on record.
Retort Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0045523). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website retortpharma.com.
Company details
CIN U24231TN1983PTC010371
Registration Number 010371
Incorporation Date 10 October 1983
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TN-02-0045523
Recognitions & Rankings of Retort Pharmaceuticals
Contact details
Retort Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its website is retortpharma.com. Its e-mail address is in the company report.
- Email
- Website
- Registered Address21 Mc. Nichols Road Chetput Madras – 31., Chennai, Tamil Nadu, India – 600031
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Retort Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Retort Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Retort Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Retort Pharmaceuticals Private Limited, buy the company report.
Financials of Retort Pharmaceuticals Private Limited
FY 2025 filings availableRetort Pharmaceuticals Private Limited reported revenue of ₹1.97 Cr (down 7% YoY) for FY 2024.
Revenue · FY 2024
₹1.97 Cr ▼ 7%
Net loss · FY 2024
₹3.34 Lakh margin -1.7%
EBITDA · FY 2024
₹64,813 margin 0.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 7%
3 years · compounded
▼ 9%
5 years · compounded
▼ 2%
EBITDA CAGR growth
1 year
▲ 122%
3 years · compounded
▼ 68%
5 years · compounded
▼ 28%
Revenue has declined at a compounded annual rate (CAGR) of 2% over five years, including a 7% fall in the latest year. EBITDA rose 122% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹64,813 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.34 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.3% | ||||
| Net Profit Margin | -1.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Retort Pharmaceuticals Private Limited, buy the company report.
Board of directors of Retort Pharmaceuticals Private Limited
Retort Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nandita Thakkar | Director | 29 Apr 2021 | 5 Years 6 Months | Current |
| Varun Ashok Thakkar Also directs: Viking Bulk Cargo Terminals Private Limited | Director | 23 Nov 2023 | 2 Years 11 Months | Current |
Peer comparison
Retort Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Amrutam Pharmaceuticals Private Limited | ₹1.98 Cr (FY 2024) | -11.0% | Gwalior, Madhya Pradesh, India | |||
| BLBK Pharmaceuticals Private Limited | ₹1.98 Cr (FY 2025) | -27.0% | Delhi, India | |||
| Asperia Lifesciences Private Limited | ₹1.98 Cr (FY 2025) | 29.0% | Jaipur, Rajasthan, India | |||
| Retort Pharmaceuticals Private Limitedthis company | ₹1.97 Cr (FY 2024) | -₹3.34 Lakh | -1.7% | -7.0% | 30 | Chennai, Tamil Nadu, India |
| Immunity Healthcare Private Limited | ₹1.97 Cr (FY 2024) | -1.0% | Ahmedabad, Gujarat, India | |||
| Tooba Pharmaceuticals Private Limited | ₹1.97 Cr (FY 2024) | 57.0% | Aurangabad, Maharashtra, India | |||
| Fortune Pharmaceuticals India Private Limited | ₹1.97 Cr (FY 2024) | -74.0% | Samba, Jammu and Kashmir, India |
To see the full peer comparison of Retort Pharmaceuticals Private Limited, buy the company report.
Auditor
Retort Pharmaceuticals Private Limited is audited by J L R & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J L R & CO | FY 2021 | 003323S |
Shareholding
The shareholding of Retort Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Retort Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹4.7 Lakh
Satisfied charges
₹16 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Feb 2009 | 10151053 | Indian Bank | ₹4.7 Lakh | Open | |
| 30 Aug 1995 | 90288869 | Andhra Bank | ₹16 Lakh | Satisfied |
To see the full charge records of Retort Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Retort Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Retort Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Retort Pharmaceuticals Private Limited has a workforce of 30 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
Employee count
30
Active EPFO establishments
1
Employee growth
-25%
GST
Retort Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAACR2993J1Z7 | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Retort Pharmaceuticals Private Limited, buy the company report.
Recent activity
Retort Pharmaceuticals Private Limited has 6 board changes on record since 2021: 2 appointments and 4 cessations. The latest: Varun Ashok Thakkar ceased to be Additional Director on 29 Sep 2024.
AGM
Retort Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Retort Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Ceased
Varun Ashok Thakkar ceased to be Additional Director.
Ceased
Kiran Vijaykumar Mehta ceased to be Director.
Appointed
Varun Ashok Thakkar was appointed as Director.
Ceased
Vijay Anantarai Mehta ceased to be Director.
Ceased
Nandita Thakkar ceased to be Additional Director.
Appointed
Nandita Thakkar was appointed as Director.
Charges
A charge with Indian Bank of Rs. 4.70 Lakh registered on 19 Feb 2009 with Charge ID 10151053 was modified on 04 Jun 2020.
Charges
A charge registered on 30 Aug 1995 via Charge ID 90288869 with Andhra Bank was fully satisfied on 19 Nov 2010.
Charges
A charge with Indian Bank amounted to Rs. 4.70 Lakh with Charge ID 10151053 was registered on 19 Feb 2009.
Charges
A charge with Andhra Bank of Rs. 16.00 Lakh registered on 30 Aug 1995 with Charge ID 90288869 was modified on 28 Jul 2008.
2 earlier events are in the company report.
Frequently asked questions
Retort Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 October 1983 (43+ years old) and is registered under CIN U24231TN1983PTC010371.
Retort Pharmaceuticals has 2 current directors:
- Nandita Thakkar - Director
- Varun Ashok Thakkar - Director
The latest financial statements of Retort Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Retort Pharmaceuticals is 33AAACR2993J1Z7, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Retort Pharmaceuticals is U24231TN1983PTC010371. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Retort Pharmaceuticals was incorporated on 10 October 1983, making it 43+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Retort Pharmaceuticals by revenue are Amrutam Pharmaceuticals Private Limited, BLBK Pharmaceuticals Private Limited, Asperia Lifesciences Private Limited, Immunity Healthcare Private Limited, Tooba Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Varun Ashok Thakkar ceased to be Additional Director on 29 Sep 2024. Kiran Vijaykumar Mehta ceased to be Director on 07 Dec 2023. Varun Ashok Thakkar was appointed as Director on 23 Nov 2023. Retort Pharmaceuticals has 6 board changes on record in total.
Yes, Retort Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-02-0045523).
Retort Pharmaceuticals can be reached through the website retortpharma.com. Its registered office is in Chennai, Tamil Nadu, India.
The registered office of Retort Pharmaceuticals is at 21 Mc. Nichols Road Chetput Madras – 31., Chennai, Tamil Nadu, India – 600031.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages